What is the mortality rate of testicular cancer?

Testicular cancer is a very serious malignant tumor disease. This disease has complex causes. Once the disease occurs, it is not easy to recover. If we want to say goodbye to the disease, we must pay attention to scientific treatment, so that we can recover earlier and reduce some unnecessary troubles. The following editor will talk about whether the mortality rate of testicular cancer is high?

Is the mortality rate of testicular cancer high? This question is often asked by testicular cancer patients and their families in clinic. Experts say: It is not possible to draw a single conclusion on this issue. You should go to the hospital for diagnosis in time. If it is in the early stage of testicular cancer, it can be treated by surgery with good prognosis. If it is in the middle and late stages, then the main thing is how to prolong life. In fact, no matter what stage of the disease, maintaining a good mood and mental state is beneficial to restoring health.

As one of the most common cancers in young men, the cause of testicular cancer is not well known. According to statistics, the incidence rate of testicular cancer in men is 7 per 100,000, and it is increasing year by year. The cause is usually the metastasis of malignant tumors.

Research has found that the interval between two testicles getting cancer can be as long as 25 years. The mortality rate of testicular cancer in the United States has dropped significantly in recent years, from 19% in 1970 to 10% in 1990. Such treatment results make the medical community proud, but it also makes patients often take it lightly and not have regular physical examinations, which has led to an increase in the metastasis and recurrence rates of testicular cancer.

Cancer research reports indicate that in a retrospective survey of 2,088 testicular cancer patients, 21 patients had cancer cells in both testicles, and more than half of them found out that the second testicle also had cancer five years after the testicular cancer was confirmed. The results show that 2 to 4 percent of testicular cancer patients will relapse in the same part after being cured, and 1 percent of testicular cancer patients will also have cancer in the second testicle. In other words, the probability of testicular cancer patients getting testicular cancer again after being cured is 500-1,000 times that of normal people.

Regular annual physical examinations are the key to early detection of symptoms. For patients who have been successfully treated for testicular cancer, in order to avoid the metastasis and recurrence of testicular cancer, they should have a check-up every month to prevent the unfortunate event from happening again.

Testicular tumors have a good prognosis, with 95% of early-stage patients surviving for a long time. Advanced tumors can be treated with radiotherapy, chemotherapy, and high-dose chemotherapy supported by hematopoietic stem cells, with a five-year survival rate of 80%, but the cost of treatment is high; recurrent and metastatic cases are prone to drug resistance, with a long-term survival rate of only 15%. Early detection and diagnosis of testicular tumors are very important. Clinically, lesions can be detected early through scrotal light transmission tests, B-ultrasound, CT examinations, biopsy and pathological examinations, and regular self-examinations can also help detect lesions early.

(i) Complete spontaneous regression is rare.

(II) All adult reproductive cell tumors should be considered malignant. The so-called "benign teratomas" have ductal invasion under the microscope. Ultimately, 29% of patients who undergo simple orchiectomy die from the tumor. Teratomas in children are benign.

(3) The tunica albuginea is a natural barrier. Tumors often penetrate the mediastinum, where blood vessels, lymphatic vessels, nerves and tubules pass through. Ten to fifteen percent of cases expand to the epididymis and spermatic cord, increasing the risk of lymphatic and bloodstream recurrence and metastasis.

(IV) All testicular tumors are prone to lymphatic recurrence and metastasis, although pure choriocarcinoma can also spread to the blood. The 4-8 lymphatic vessels of the spermatic cord fan out upward to the retroperitoneal lymph chain. The first lymph nodes reached by the right testicle are the lymph nodes in the aortic interval of the L3 vertebral body, and the first-tier lymph nodes of the left testicle are in the para-aortic area: the left ureter, renal vein, and the beginning of the inferior mesenteric artery and the aorta. It can reach the chylous pool, thoracic duct, and supraclavicular lymph nodes (mainly on the left side), and can also recur and metastasize downward to the iliac and inguinal lymph nodes. Inguinal disease can also be caused by pathological changes, recurrence, metastasis, and metastasis.

(V) Recurrence and metastasis outside lymph nodes Metastasis can directly invade blood vessels or tumor thrombus spread from lymphatic venous anastomosis. Most hematogenous recurrence and metastasis occur after lymphatic recurrence and metastasis. If stage A non-seminoma tumor cells only undergo orchiectomy, 20% of them are stage A, most of which, that is, 80%, are retroperitoneal recurrence and metastasis lymph nodes, and 20% of recurrence and metastasis are not related to it. Pure seminoma tumor cell tumor recurrence and metastasis are often seminoma tumor cells, less than 10% are other components of recurrence and metastasis, and those with other components of recurrence and metastasis account for 30% to 45% of the deaths of pure seminoma tumor cells.

Through the above editor's narration, we can understand that testicular cancer has a relatively high mortality rate. We hope that after understanding these common sense about testicular cancer, we can correctly view testicular cancer in the future, attach importance to the prevention and treatment of testicular cancer, and strive to make every man effectively stay away from testicular cancer.